Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

phase 2 clinical trial

POPULAR ARTICLES

Catabasis to Evaluate Muscular Dystrophy Treatment

NASDAQ:CYTK

pharmaceutical investing

Cytokinetics Starts Phase 2 Clinical Trial for Cardiomyopathy Treatment

BioXcel Therapeutics to Expand BXCL701 Study

LATEST ARTICLES

Mustang Bio Announces Additional Clinical Data on MB-107

NASDAQ:CARA

Cara Therapeutics Tumbles on Phase 2 Oral KORSUVA Results

pharmaceutical investing

Rafael Pharmaceuticals Expands Phase 2 CPI-613 Trial

NASDAQ:VRCA

pharmaceutical investing

Verrica Pharmaceuticals Dips on FDA IND Acceptance

Bio-Path Holdings Completes Safety Testing Study in Stage 2 of Phase 2 Trial

Anchiano Discontinues Phase 2 Codex Study

AzurRx BioPharma Announces Positive Phase 2 Trial Results of MS1819

XORTX Reports Positive Phase 2 Results in Type 2 Diabetic Nephorpathy

pharmaceutical investing

Foamix Enrolls First Patient in Phase 2 Acne Clinical Trial

Aduro Biotech Doses First Patient in Phase 2 Study of ADU-S100

Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial

pharmaceutical investing

Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat

Latest News

Allied Critical Metals: Advancing Tungsten Projects in Portugal

E-Power Resources Inc. Announces Closing of Oversubscribed Hard Dollar and Flow-through Private Placements

Canadian Investment Regulatory Organization Trade Resumption - CYG

Galan Lithium Limited: A$20 million Placement to Strategic Partner

Prospectus

Featured Stocks

Allied Critical Metals

ACM:CC

Brightstar Resources

BTR:AU

Coelacanth Energy

CEI:CC

Brunswick Exploration

BRW:TCM

Stallion Uranium

STUD:CC

Harvest Gold

HVG:CC

More featured stocks